Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Watch Best of BIO
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Addressing Climate Change
    Strengthening the Bioeconomy
    Growing Trust in Innovation
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    Learn More >
  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO International Convention

    June 5-8, 2023 | Boston, MA
    Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership

    Learn more
    Teal Box Mega Nav
    BIO Partnering at JPM Week

    January 9-12, 2023 | San Francisco, CA

    Teal Box Mega Nav
    BIO CEO & Investor Conference

    February 6-9, 2023 | New York, NY

    Teal Box Mega Nav
    BIO-Europe Spring

    March 20-22, 2023, Basel Switzerland
     

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • BIO Media
    BIO Media

    Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.

    I am BIO Podcast
    Good Day BIO Newsletter
    I am BIO Video
    Join Today
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
384 Results Found

Covid Vaccine
COVID-19 Pandemic, Two Years Later
Two years ago, the World Health Organization (WHO) declared COVID-19 a “pandemic.” We look back at key activities from BIO and the biopharmaceutical industry—and where we go from here.

Covid Vaccine
We Can and Must SHARE Vaccines with the Globe
What will it take to end the pandemic? A true return to normalcy includes international travel and the movement of people globally. But how do we do this safely? How do we get vaccines to poorer areas of the world? As BIO CEO Dr. Michelle McMurry-Heath says in the latest episode of I am BIO, …

innovation-drug
Made in America Week: Celebrating America’s Vibrant Biopharma Industry
This week is “Made in America Week.” According to the president, this is a time to pay special tribute to U.S. innovators, builders, entrepreneurs, and “all those who work with their hands every day to make America great.” We certainly have a lot to celebrate! As Under Secretary of Commerce for…

Scientist in lab
Q&A: Senator Tillis on the Vital Link Between Intellectual Property Protections & Innovation
With the 40th anniversary of the Bayh-Dole Act this year, BIO connected with Senator Thom Tillis (R-NC), Chairman of the Senate Subcommittee on Intellectual Property, for a discussion about the importance of intellectual property and innovation. BIO: This year is the 40th anniversary of the Bayh…

Gavel sitting on top of a book that reads PATENT LAW
#TBT: Debunking Some Common Myths on Patent Protections
The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine the U.S. patent system this morning. Ahead of the hearing – and in honor of #ThrowBackThursay – we are resurfacing a piece by BIO’s Tom DiLenge that helps debunk some of the most…

BTN-MTC_Patient-Pharmacy.png
How Can We Control Drug Costs While Supporting Innovation?
As the debate on drug pricing continues, our elected leaders will almost certainly adopt policies that will significantly impact—for better or for worse—the lives of many patients. With that in mind, how we do we ensure patients are at the center of this discussion? It starts by recognizing some…

Gavel sitting on top of a book that reads PATENT LAW
BIO’s Hans Sauer Calls for Less Confusing Patent Eligibility Standards
Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of three hearings in the Intellectual Property Subcommittee of the Senate Judiciary Committee on the subject of “The State of Patent Eligibility in America.” The hearings are looking at Section 101…

Gavel sitting on top of a book that reads PATENT LAW
Licensing of Research Has Had Huge Impact on Economy & Jobs
A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately comes from public funding of early-stage basic research. The licensing of this research has significantly expanded US gross domestic product, industrial gross output, and jobs over the last 22 years.  …

Hands putting a drop of liquid substance into a tube
Setting the Record Straight on March-In Rights
In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government has the power to effectively impose price controls over products that have a link to federally-funded research through its patent “march-in” rights under the Bayh-Dole…

Gavel sitting on top of a book that reads PATENT LAW
When Intervention Stifles Innovation
Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore School of Law shared his objections to legislative proposals that falsely link drug costs with patents in an op-ed that ran in The Washington Times this week. As Dolin states, current legislative proposals would…

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Impact Ag & Environment Conference
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO DOUBLE HELIX SPONSORS
Sanofi logo
Amgen logo
Bristol Myers Squibb
Genentech logo
Merck_logo_2022
BIO HELIX SPONSORS
Pfizer Inc Logo
Eli Lilly and Company
AbbVie Logo
Johnson and Johnson
Travere logo
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO